Your browser doesn't support javascript.
loading
The UK-PBC risk scores: Derivation and validation of a scoring system for long-term prediction of end-stage liver disease in primary biliary cholangitis.
Carbone, Marco; Sharp, Stephen J; Flack, Steve; Paximadas, Dimitrios; Spiess, Kelly; Adgey, Carolyn; Griffiths, Laura; Lim, Reyna; Trembling, Paul; Williamson, Kate; Wareham, Nick J; Aldersley, Mark; Bathgate, Andrew; Burroughs, Andrew K; Heneghan, Michael A; Neuberger, James M; Thorburn, Douglas; Hirschfield, Gideon M; Cordell, Heather J; Alexander, Graeme J; Jones, David E J; Sandford, Richard N; Mells, George F.
Afiliação
  • Carbone M; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Sharp SJ; Division of Gastroenterology and Hepatology, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Flack S; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Paximadas D; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Spiess K; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Adgey C; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
  • Griffiths L; Liver Unit, Royal Victoria Hospital, Belfast, United Kingdom.
  • Lim R; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Trembling P; Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.
  • Williamson K; Liver Unit, Barts and the London NHS Trust, London, United Kingdom.
  • Wareham NJ; Translational Gastroenterology Unit, John Radcliffe Hospital, Oxford, United Kingdom.
  • Aldersley M; MRC Epidemiology Unit, University of Cambridge, Cambridge, United Kingdom.
  • Bathgate A; Liver Unit, St James's University Hospital, Leeds, United Kingdom.
  • Burroughs AK; Scottish Liver Transplant Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom.
  • Heneghan MA; Sheila Sherlock Liver Center, The Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Neuberger JM; Institute of Liver Studies, King's College Hospital NHS Foundation Trust, London, United Kingdom.
  • Thorburn D; Liver Unit, Queen Elizabeth Hospital, Birmingham, United Kingdom.
  • Hirschfield GM; Sheila Sherlock Liver Center, The Royal Free London NHS Foundation Trust, London, United Kingdom.
  • Cordell HJ; Center for Liver Research and NIHR Biomedical Research Unit, University of Birmingham, Birmingham, United Kingdom.
  • Alexander GJ; Institute of Genetic Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Jones DE; Division of Gastroenterology and Hepatology, Addenbrooke's Hospital, Cambridge, United Kingdom.
  • Sandford RN; Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom.
  • Mells GF; Academic Department of Medical Genetics, University of Cambridge, Cambridge, United Kingdom.
Hepatology ; 63(3): 930-50, 2016 Mar.
Article em En | MEDLINE | ID: mdl-26223498

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Ursodesoxicólico / Colangite / Doença Hepática Terminal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ácido Ursodesoxicólico / Colangite / Doença Hepática Terminal Tipo de estudo: Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male / Middle aged Idioma: En Revista: Hepatology Ano de publicação: 2016 Tipo de documento: Article País de afiliação: Reino Unido